OHSU News

Good morning. Here are your news highlights from OHSU News.

Time magazine names OHSU’s Mitalipov one of America’s most influential people in health care

Time magazine names OHSU’s Mitalipov one of America’s most influential people in health care

The embryologist was recognized for his work utilizing gene-editing tools to prevent inherited disease.
Sleep apnea more deadly when patients experience short interrupted breaths

Sleep apnea more deadly when patients experience short interrupted breaths

Study shows patients with sleep apnea who have short interruptions in breathing while sleeping are at higher risk for death than those with longer interruptions.
Measuring the Facebook effect among veterans

Measuring the Facebook effect among veterans

A first-of-its kind study finds face-to-face contact reduces the risk of mental health problems among military veterans.
OHSU-led effort results in largest cancer dataset of its kind

OHSU-led effort results in largest cancer dataset of its kind

A study involving hundreds of patient samples may reveal new treatment options for patients facing an aggressive form of leukemia.
NIH awards OHSU nearly $4 million to test genome editing technologies

NIH awards OHSU nearly $4 million to test genome editing technologies

Scientists will create a testing model to help ensure techniques are safe and effective in future therapeutic uses.
High hopes for 4-year-old’s vision after gene therapy

High hopes for 4-year-old’s vision after gene therapy

Caspian Soto is among the first patients in Oregon to receive a new gene therapy treatment for a rare, blindness-causing mutation.